BRULLO, CHIARA
BRULLO, CHIARA
100006 - Dipartimento di Farmacia
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors
2009-01-01 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Schenone, Silvia; Spisani, S; Falzarano, Ms; Varani, K; Barocelli, E; Ballabeni, V; Giorgio, C; Tognolini, M.
2,3-Dihydro-1H-imidazo[1,2-b]pyrazole derivatives as potential neutrophils functions inhibitors
2006-01-01 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Spisani, S; Falzarano, M. S.
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation
2007-01-01 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; M., Tognolini; V., Ballabeni; E., Barocelli
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity
2003-01-01 Schenone, Silvia; Bruno, Olga; Ranise, Angelo; Brullo, Chiara; Bondavalli, Francesco; W., Filippelli; F., Mazzeo; A., Capuano; G., Falcone
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis
2007-01-01 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; FALZARANO M., S; Varani, K; Spisani, S.
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors.
2014-01-01 Rotolo, Chiara; Massa, Matteo; Meta, Elda; Brullo, Chiara; Bruno, Olga
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
2009-01-01 F., Falchi; F., Manetti; F., Carraro; A., Naldini; G., Maga; E., Crespan; Schenone, Silvia; Bruno, Olga; Brullo, Chiara; M. Botta, .
4-Amino-pyrazolo[3,4-d]pyrimidines with antiproliferative activity on osteosarcoma cell line SaOS-2
2005-01-01 Schenone, Silvia; Bondavalli, Francesco; Brullo, Chiara; Bruno, Olga; Ranise, A.; Mosti, L.; Menozzi, G.; Fossa, Paola; Santucci, A.; Serchi, T.; Spreafico, A.; Botta, M.
5-alkoxy-2-hydrazino and 5-methoxy-2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity
2005-01-01 Bruno, Olga; Brullo, Chiara; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco; Tognolini, M; Ballabeni, V; Barocelli, E.
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma
2014-01-01 Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta,
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors.
2013-01-01 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A1 receptors ligands: past, present and future trends.
2010-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
An update on dual Src/Abl inhibitors
2012-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
Analogs, formulations and derivatives of imatinib: A patent review
2015-01-01 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
ATP-competitive inhibitors of mTOR: an update.
2011-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Bcr-Abl tyrosine kinase inhibitors: A patent review
2015-01-01 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti:sintesi ed attività antipiastrinica
2004-01-01 Brullo, Chiara; Bruno, Olga; Schenone, S; Ranise, A; Bondavalli, F; Tognolini, M; Ballabeni, V; Barocelli, E.
Benzopirano[4,3-d]pirimidine e Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti: sintesi ed attività antipiastrinica
2004-01-01 Brullo, Chiara; Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco
Benzopirano[4,3-d]pirimidine e Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti: sintesi ed attività antipiastrinica
2004-01-01 Brullo, Chiara; Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco; Tognolini, M.; Ballabeni, V.; Barocelli, E.
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
2020-01-01 Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors | 1-gen-2009 | Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Schenone, Silvia; Spisani, S; Falzarano, Ms; Varani, K; Barocelli, E; Ballabeni, V; Giorgio, C; Tognolini, M. | |
2,3-Dihydro-1H-imidazo[1,2-b]pyrazole derivatives as potential neutrophils functions inhibitors | 1-gen-2006 | Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Spisani, S; Falzarano, M. S. | |
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation | 1-gen-2007 | Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; M., Tognolini; V., Ballabeni; E., Barocelli | |
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity | 1-gen-2003 | Schenone, Silvia; Bruno, Olga; Ranise, Angelo; Brullo, Chiara; Bondavalli, Francesco; W., Filippelli; F., Mazzeo; A., Capuano; G., Falcone | |
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis | 1-gen-2007 | Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; FALZARANO M., S; Varani, K; Spisani, S. | |
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. | 1-gen-2014 | Rotolo, Chiara; Massa, Matteo; Meta, Elda; Brullo, Chiara; Bruno, Olga | |
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors. | 1-gen-2009 | F., Falchi; F., Manetti; F., Carraro; A., Naldini; G., Maga; E., Crespan; Schenone, Silvia; Bruno, Olga; Brullo, Chiara; M. Botta, . | |
4-Amino-pyrazolo[3,4-d]pyrimidines with antiproliferative activity on osteosarcoma cell line SaOS-2 | 1-gen-2005 | Schenone, Silvia; Bondavalli, Francesco; Brullo, Chiara; Bruno, Olga; Ranise, A.; Mosti, L.; Menozzi, G.; Fossa, Paola; Santucci, A.; Serchi, T.; Spreafico, A.; Botta, M. | |
5-alkoxy-2-hydrazino and 5-methoxy-2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity | 1-gen-2005 | Bruno, Olga; Brullo, Chiara; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco; Tognolini, M; Ballabeni, V; Barocelli, E. | |
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma | 1-gen-2014 | Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta, | |
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. | 1-gen-2013 | Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M. | |
A1 receptors ligands: past, present and future trends. | 1-gen-2010 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M. | |
An update on dual Src/Abl inhibitors | 1-gen-2012 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M. | |
Analogs, formulations and derivatives of imatinib: A patent review | 1-gen-2015 | Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica | |
ATP-competitive inhibitors of mTOR: an update. | 1-gen-2011 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M. | |
Bcr-Abl tyrosine kinase inhibitors: A patent review | 1-gen-2015 | Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca | |
Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti:sintesi ed attività antipiastrinica | 1-gen-2004 | Brullo, Chiara; Bruno, Olga; Schenone, S; Ranise, A; Bondavalli, F; Tognolini, M; Ballabeni, V; Barocelli, E. | |
Benzopirano[4,3-d]pirimidine e Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti: sintesi ed attività antipiastrinica | 1-gen-2004 | Brullo, Chiara; Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco | |
Benzopirano[4,3-d]pirimidine e Benzopirano[4,3-d]pirimidin-5-oni 2,4-disostituiti: sintesi ed attività antipiastrinica | 1-gen-2004 | Brullo, Chiara; Bruno, Olga; Schenone, Silvia; Ranise, Angelo; Bondavalli, Francesco; Tognolini, M.; Ballabeni, V.; Barocelli, E. | |
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma | 1-gen-2020 | Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C. |